Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

Nature Medicine
Vesna Jevtovic-TodorovicJ W Olney

Abstract

Extensive research has failed to clarify the mechanism of action of nitrous oxide (N2O, laughing gas), a widely used inhalational anesthetic and drug of abuse. Other general anesthetics are thought to act by one of two mechanisms-blockade of NMDA glutamate receptors or enhancement of GABAergic inhibition. Here we show that N2O, at anesthetically-relevant concentrations, inhibits both ionic currents and excitotoxic neurodegeneration mediated through NMDA receptors and, like other NMDA antagonists, produces neurotoxic side effects which can be prevented by drugs that enhance GABAergic inhibition. The favorable safety record of N2O may be explained by the low concentrations typically used and by the fact that it is usually used in combination with GABAergic anesthetics that counteract its neurotoxic potential.

Associated Clinical Trials

References

Dec 6, 1991·Science·J W OlneyM A Sesma
Sep 1, 1989·Biological Psychiatry·J W Olney
Feb 1, 1989·Anesthesiology·N W MahmoudiH M Shapiro
Sep 23, 1987·European Journal of Pharmacology·J OlneyG Frierdich
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E H WongL L Iversen
Jan 22, 1982·European Journal of Pharmacology·D Lodge, N A Anis
Jul 1, 1982·Anesthesia and Analgesia·T F HornbeinK H Smith
Feb 17, 1994·Nature·N P Franks, W R Lieb
Jun 23, 1995·Neuroscience Letters·M IshimaruJ W Olney
Feb 1, 1993·Drug and Alcohol Dependence·C S DohrnJ P Zacny
Feb 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·V Jevtović-TodorovićJ W Olney

❮ Previous
Next ❯

Citations

Jul 2, 2008·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Davide CattanoChainllie Young
Dec 7, 2007·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Masahiro IrifuneMichio Kawahara
Apr 24, 2007·Neurotoxicity Research·Angela M Kaindl, Chrysanthy Ikonomidou
Sep 16, 1999·Cellular and Molecular Life Sciences : CMLS·M D Krasowski, N L Harrison
Mar 22, 2006·Psychopharmacology·Clare L LittlewoodSteven C R Williams
Dec 6, 2008·Psychopharmacology·M G Whalley, G B Brooks
Sep 29, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yuheng WangJunke Wang
Jun 2, 2006·Apoptosis : an International Journal on Programmed Cell Death·Lucy X LuVesna Jevtovic-Todorovic
Jan 12, 2011·Sleep & Breathing = Schlaf & Atmung·Stephane BesnardChristian Gestreau
Dec 22, 2010·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Berthold DrexlerUwe Rudolph
Dec 25, 2010·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Dian-Shi Wang, Beverley A Orser
Jul 21, 2011·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Kevin LaskowskiHyun J Lim
Mar 17, 2004·Trends in Pharmacological Sciences·John W OlneyChrysanthy Ikonomidou
Mar 26, 2003·Brain Research·Karl J KaiyalaDouglas S Ramsay
Jan 11, 2003·Neurotoxicology·John W Olney
Dec 22, 1999·Trends in Pharmacological Sciences·D BelelliJ J Lambert
May 30, 2002·Progress in Neurobiology·Mark J Millan
Aug 28, 1999·Progress in Neurobiology·T Yamakura, K Shimoji
Feb 19, 2002·Brain Research Bulletin·Edömer TassonyiDaniel Bertrand
Jul 24, 2013·Lab Animal·Rachel K RoweJonathan Lifshitz
Apr 18, 1998·Nature Medicine·N P Franks, W R Lieb
Aug 24, 2004·Nature Reviews. Neuroscience·Uwe Rudolph, Bernd Antkowiak
Apr 22, 2008·Nature Reviews. Neuroscience·Nicholas P Franks
Aug 6, 2000·British Journal of Pharmacology·V Jevtovic-TodorovicJ W Olney
Jan 13, 2005·British Journal of Pharmacology·Pavle M JoksovicSlobodan M Todorovic
Aug 18, 2000·Anaesthesia·J de LimaC Torsney
Jan 10, 2003·Paediatric Anaesthesia·Hideaki HayashiSulpicio G Soriano
Jun 28, 2003·Neurotoxicity Research·John W OlneyChrysanthy Ikonomidou
Oct 24, 2002·British Journal of Anaesthesia·D MaN P Franks
Jun 27, 2013·British Journal of Anaesthesia·K de Vasconcellos, J R Sneyd
Jul 12, 2008·International Anesthesiology Clinics·Stuart A Forman, Victor A Chin
Sep 25, 2008·Journal of Neurosurgical Anesthesiology·Sibel KahramanGary Fiskum
Jun 6, 2009·European Journal of Anaesthesiology·Andrea Kopp LugliChristoph H Kindler
Sep 9, 2009·Cephalalgia : an International Journal of Headache·C Ayata
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·T YamakuraR A Harris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.